The global iron deficiency anemia market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2022-2028). The increasing number of cases associated with haemodilution in pregnancy across the globe is one of the prime factors affecting and driving the market for iron deficiency anemia. Haemodilution generally occurs during pregnancy and the most common causes of anemia during pregnancy are iron deficiency and folate acid deficiency. Additionally, the changes in lifestyle which are more in developed and developing countries, are resulting in irregular BMI, and an increase in abnormal weight which in turn is disturbing the physiology of a pregnant woman impacting the market.
Browse the full report description of “Global Iron Deficiency Anemia Market Size, Share & Trends Analysis Report By Therapy Type (Intravenous Iron Therapy, Oral Iron Therapy, Red Blood Cell Transfusion, and Others), By End-User (Hospitals & Clinics, and Home Healthcare) Forecast, 2022-2028” at https://www.omrglobal.com/industry-reports/iron-deficiency-anemia-market
Moreover, to gain on the opportunity key players operating in the global iron deficiency anemia market had been adopting strategies such as new launches to achieve major market share. For instance, in July 2021, one of the divisions of Novartis AG that is Sandoz had introduced generic Ferumoxytol in the US which is an intravenous medication used for the purpose of treatment of iron deficiency anemia (IDA). Through this launch, the company would continue to build its hospital and clinic portfolio along with offering access to affordable generic medicines.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Therapy Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- AMAG Pharmaceuticals, Bayer AG, Novartis AG, Sanofi, and Pieris Pharmaceuticals, Inc.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Iron Deficiency Anemia Market Report Segment
By Therapy Type
By End-User
Global Iron Deficiency Anemia Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/iron-deficiency-anemia-market